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Introduction
It is commonly known that deep hypothermia dramati-
cally reduces the demand for glucose and oxygen. For
instance, in a study of 15 patients, suﬀering from acci-
dental deep hypothermia with circulatory arrest of
15±19 min, it was observed that none of the surviving
patients suﬀered any brain lesions visible on MRI scans,
or neurological or neuropsychological disorders [1].
Animal studies (e.g. [2]), as well as human studies [3, 4, 5,
6], have shown that induced hypothermia has a positive
therapeutic eﬀect in the treatment of stroke. Inducing
hypothermia in patients suﬀering from stroke can be
achieved by cooling the patient’s whole body (systemic
hypothermia) or by cooling the ischaemic area locally
(local hypothermia). Both methods will be discussed.
Systemic hypothermia
There is a direct relationship between body temperature,
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Abstract During the treatment of
stroke by local intra-arterial throm-
bolysis (LIT) it is frequently possible
to pass the blood clot with a micro-
catheter, allowing perfusion of brain
tissue distally to the occlusion. This
possibility allows for new early
treatments of ischaemic brain tissue,
even before the blood clot has been
removed. One potential new
approach to preserve brain tissue at
risk may be locally induced
endovascular hypothermia. Physical
parameters such as the required
micro-catheter input pressure,
output velocity and ﬂow rates, and a
heat exchange model, applicable in
the case of a micro-catheter placed
within a guiding catheter, are
presented. Also, a simple cerebral
temperature model is derived that
models the temperature response of
the brain to the perfusion with
coolant ﬂuids. Based on this model,
an expression has been derived for
the time needed to reach a certain
cerebral target temperature. Experi-
mental in vitro measurements are
presented that conﬁrm the usability
of standard commercially available
micro-catheters to induce local
hypothermia of the brain. If applied
in vivo, the model predicts a local
cooling rate of ischaemic brain tissue
of 300 g of approximately 1C in
1 min, which is up to a factor
30-times faster than the time-con-
suming systemic hypothermia via the
skin. Systemic body temperature is
only minimally aﬀected by
application of local hypothermia,
thus avoiding many limitations and
complications known in systemic
hypothermia.
Keywords Hypothermia Æ Heat
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that the metabolic rate is proportional toM 3/4 exp()Ei/
kBT), in which M is the body mass, T the body temper-
ature, Ei the average activation energy for metabolic
reactions (in the range of 0.2–1.2 eV), and kB is Boltz-
mann’s constant. Under the assumption that the average
enzyme-catalysed activation energy ÆEiæ equals 0.6 eV,
lowering the human body temperature by 1C results in
an 8% lower metabolic rate. As a slowed metabolism has
less need for oxygen and glucose [8], cooled ischaemic
tissue is able to sustain an ischaemic/hypoxic period for a
longer time.
Classical ways of cooling the body include the use of
ﬂuid-circulating cooling blankets, electric fans, rubbing
patients with alcohol/water solutions and lowering
ambient temperature. Very recent technological devel-
opments are special cooling devices that allow the
induction of moderate hypothermia (body temperature
of 34C) within an hour (e.g. Celsius Control System,
Innercool Therapies, San Diego, Calif., USA, and the
SetPoint Endovascular temperature therapy system,
Radiant Medical, Redwood City, Calif., USA). Both
systems make use of specially developed heat-exchange
catheters that are placed in the inferior vena cava. Clin-
ical tests have been carried out and are currently being
performed with these new devices in multi-centre studies,
investigating the inﬂuence of hypothermia therapy in
myocardial infarction (COOL MI [9]) and investigating
the eﬀect of induced hypothermia in severe stroke due to
middle cerebral artery occlusion (COOL AID [10]). As in
the classic way of inducing hypothermia via the skin,
these new endovascular cooling devices also induce
whole-body hypothermia. The time to reach mild hypo-
thermia of 32 to 33 body core temperature is reported
to be, on average, 3.5 h with the classical methods, and
roughly 1 h with the new endovascular devices.
Local hypothermia
There are several ways to induce local hypothermia in
the brain. Cooling of the brain via the skull with the aid
of a cooling helmet has been described very recently [11].
Due to the slow thermal conduction of heat from the
brain to the helmet, it takes on average 3.4 h to cool the
brain down to 34C, which is a considerably long time
when compared with the therapeutic window. The
method is also reported to reduce the systemic temper-
ature to values lower that 36C after 6.7 h. Another way
of cooling the brain locally was proposed by Noguchi
et al. [12], who used cold saline solution to perfuse the
subdural space in a rat study. The results presented are
promising, but the drawback of this method is that the
skull needs to be opened, which is a major disadvantage
for clinical use in the case of stroke.
A third way to induce local hypothermia is by local
intra-arterial perfusion with cold saline solution. Owing
to the fact that the cold liquid is transported through the
microvasculature, the heat exchange is most eﬃcient,
and cooling can be achieved very rapidly, as will be
shown in this paper. During the review process of this
paper, a study by Ding et al. [13] was published, showing
the ﬁrst results of a local endovascular cooling method,
similar to that proposed in this paper, applied to rats
after transient middle cerebral artery occlusion. Ding
et al. showed that local endovascular induced hypo-
thermia signiﬁcantly reduced the infarct volume by 90%
and improved the motor behaviour of rats signiﬁcantly
when compared with non-treated rats.
This paper deals with a physical feasibility study of
whether it is possible to induce local hypothermia
of the ischaemic brain area in human beings by the
use of standard guiding catheters—and micro-cathe-
ters—which are used in the daily routine of interven-
tional neuroradiology, especially the well-established
stroke treatment by local intra-arterial thrombolysis
(normally used for intra-arterial thrombolysis).
Methods
Local intra-arterial thrombolysis (LIT) using pro-uro-
kinase has been found to improve the outcome of
patients with acute M1 or M2 segment occlusions of the
middle cerebral artery (MCA) (PROACT study [14])
when administered within 6 h [15]. In addition, several
series showed that LIT could be safely and eﬃcaciously
applied in everyday practice in middle cerebral artery
[16] or basilar artery occlusion [17]. From the meth-
odological point of view, LIT is a safe, quick and easily
performed neuro-radiological intervention: the tip of a
ﬁve, up to an eight, French guiding catheter is placed
in the vertebral or internal carotid artery by a trans-
femoral approach and a micro-catheter, mostly a
FasTracker 18 (Boston Scientiﬁc), is navigated through
this guiding catheter in front of (PROACT) or into the
occluded intracranial blood vessel [17]. Figure 1a shows
this situation schematically. During LIT, a thrombo-
lytic agent supplied to the patient via a micro-catheter
dissolves the occluding thrombus. Based on the expe-
rience of more than 300 patients treated with LIT in
our university-based stroke unit [18], and corresponding
with the well-known experiences of many other neuro-
radiological centres performing LIT, it frequently
occurred that the tip of the micro-catheter could pass
the site of occlusion (see Fig. 1b). This would allow an
artiﬁcial perfusion of the devascularized brain located
distally to the blood clot (Figs. 2, 3). The ability to
perfuse the core and penumbra of brain infarction even
before the thrombolytic agent has dissolved the
thrombus allows for various additional new types of
early and neuroprotective treatments of the ischaemic
brain tissue.
924
The goal of the study presented here was to determine
whether it is physically possible to induce local hypo-
thermia via a micro-catheter in a human. To answer this
question, a thermal model of the micro-catheter and a
thermal model of the infarcted brain area that models
the thermal response of the brain to cooling were
developed. These models allow the calculation of the
necessary amount of cooling ﬂuid that has to be
administered per time unit in order to reach a certain
target brain temperature within a certain amount of
time. The derived model also allows estimation of the
worst-case systemic cooling eﬀect on the body.
Owing to the theoretical nature of the subject dealt
with in this paper, this section will describe, besides the
methodological aspects of the study, theoretical aspects of
the heat-exchange processes in the human body, several
Fig. 2a–c Angiography of a 56-year-old woman with acute
left-sided hemiplegia. a Angiography of the right internal carotid
artery demonstrates the occlusion of the proximal segment of the
MCA. b The micro-catheter is navigated through the occlusion,
which is conﬁrmed by a gentle injection of contrast agent. c
Revascularization of the MCA after intra-arterial thrombolysis
(injection of one million units urokinase proximally, into, and
distal of the site of occlusion)
c
Fig. 1 a The end of the micro-catheter that releases the thrombo-
lytic agent (e.g. urokinase) is positioned such that it is very close to
the occluding blood clot. b Often it is possible to pass through the
blood clot and/or between the clot and the wall of the vessel with
the catheter allowing the reperfusion of infarcted tissue distally of
the blood clot
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physical aspects of micro-catheters as coolant carriers,
and a model that simulates the temperature response of
the brain, allowing the calculation of theoretical brain
cooling rates. Most of the thermal physics and other
physical aspects are dealt with in Appendices 1, 2 and 3.
Heat-exchange mechanisms of the human body
At basal metabolic rate, the human body produces
approximately 80–100 J/s. In order to keep its temper-
ature, the human body constantly exchanges heat with
its surrounding environment. It has the capacity to keep
its core temperature within the narrow range of 36.7–
37.7C in a very large ambient temperature range
(Benziger [19]). The temperature of the body is regulated
by neural feedback mechanisms, which operate primar-
ily through the hypothalamus. The hypothalamus con-
tains not only the control mechanisms, but also the key
temperature sensors.
Themajor heat-transfermechanismswithin the human
body and between the human body and its surrounding
environment are radiation, conduction, convection, and
evaporation of perspiration. Appendix 1 discusses these
physical heat-transfer mechanisms in more detail.
A variety of responses is initiated to conserve the heat
in the body and to increase heat production if the human
body is exposed to a cold environment, as performed in
global artiﬁcially induced hypothermia. These include
vasoconstriction to decrease the ﬂow of heat to the skin,
shivering to increase heat production in the muscles, and
the secretion of norepinephrine, epinephrine, and thy-
roxine to increase heat production. The release of epi-
nephrine, norepinephrine and thyroxine will cause
tachycardia, hypertension, and increased catabolism.
Therefore, patients with a history of atrial ﬁbrillation and
congestive heart failuremay not be suitable candidates for
systemic hypothermia (see also [10]). For these patients
local induced hypothermia would be applicable, if the
method would not lower the systemic body temperature.
Micro-catheters as coolant transporters
Micro-catheters are thin, ﬂexible, tubes that have outer
diameters in the order of 1.0–2.0 mm. Their length is in
Fig. 3a–c MRI and angiography of a 57-year-old woman with
acute aphasia and right-sided hemiparesis. a Diﬀusion-weighted
MRI (1.5 T, b=1,000) demonstrates infarction of the dorsal
territory of the middle cerebral artery. b The late arterial phase
of the angiography of the left internal carotid artery shows
corresponding deﬁcit of perfusion of the dorsal MCA branches.
c The micro-catheter is navigated into the occluded branch of the
MCA. Gentle contrast injection shows opaciﬁcation of the non-
perfused dorsal MCA area
b
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the order of 1.50 m (e.g. FasTracker; Boston Scientiﬁc).
In LIT, micro-catheters are normally used to transport
thrombolytic agents near to or into the blood clot. In
order to be able to navigate the micro-catheter into the
intracranial vessels, the tip of a so-called guiding cath-
eter, normally with a size six or seven French (one
French=0.3 mm), is ﬁrst positioned in the cervical part
of the vertebral or internal carotid artery. Within this
guiding catheter the very thin and ﬂexible micro-catheter
can easily be moved (see Fig. 1a, b). This section will
examine the physical possibility of whether the combi-
nation of guiding/micro-catheters can be used to trans-
port coolant liquids.
Heat exchange between the endovascular
micro-catheter and blood
From the femoral artery to the arch of the aorta there is
a counterﬂow between the coolant in the micro-catheter
and the blood. From the aortic arch on and in the car-
otid artery the coolant ﬂows parallel to the blood. It can
be proven [20] that the following relationship exists
between the heat ﬂow _Q; measured in joules per second,
and the temperature diﬀerences DTfemoral artery, DTbrain,
the average overall heat transfer coeﬃcient k and the
area Agc of the catheter:





where DTfemoral artery is the diﬀerence between the fem-
oral arterial blood temperature and the coolant tem-
perature at the body entry point (femoral vein), and
DTbrain is the diﬀerence between the arterial blood tem-
perature in the brain and the coolant temperature in the
brain. The overall heat-transfer coeﬃcient k can be
computed for the given geometry. It is not in the scope
of this paper to describe this constant in more detail.
This paper will focus only on the experimental deter-
mination of the overall heat-transfer coeﬃcient k, which
is of crucial importance for answering the question of
whether a micro/guiding catheter is suited to serve as a
coolant transporter. In the results section of the paper
measured values for k will be given.
Other important physical aspects of the use of micro-
catheters as coolant transporters, such as the required
micro-catheter input pressure and coolant ﬂuid outﬂow
velocity, can be found in Appendix 2. From Eq. 8 of
Appendix 2 the required input pressures were calculated.
Figure 4 shows the required input pressures as a func-
tion of the desired ﬂow rates for three diﬀerent
micro-catheter radii. For the FasTracker-18 micro-
catheter we found experimental pressure values of
approximately 800 mmHg for ﬂows /V of around
0.25 ml/s. Experimentally, the tube wall of the
FasTracker-18 (Boston Scientiﬁc) micro-catheter had no
visible diﬃculty with this high input pressure.
Brain temperature-response model
The temperature response of the brain to an endovas-
cular applied cooling ﬂuid can be calculated by solving
the so-called bio-heat equation and is dealt with in
Appendix 2. In this section, we will only apply the
solution to the simpliﬁed bio-heat equation to the case
were we assume that the volume of the infarcted brain
tissue (MIB) is 300 g, which is a realistic value for an
MCA occlusion. It is also assumed that the temperature
of the brain (TIB, 0) when cooling is started equals
37.0C. For several micro-catheter ﬂow rates and a mi-
cro-catheter outlet coolant temperature Tmc,out of
15.0C the cerebral brain temperature response was
calculated. The results are displayed in Fig. 5. As intu-
itively expected, the larger the ﬂow rate /mc,out, the
faster the tissue cools down. This simple temperature
model predicts that, for large values of time, the brain
temperature approaches the coolant temperature.
In the case of stroke, the tissue has to be cooled down
as fast as possible to mild (TIB34C) or moderate
(TIB28C) hypothermia in order to slow down the
metabolic rate, thus slowing down further acidosis, cell
swelling and cell death, and widening the treatment
window. According to Fig. 5, this mild-to-moderate
hypothermia can be achieved within 6 min under the
given circumstances.
Fig. 4 The relation between the ﬂow rate (ml/min) and the required
input pressure (mmHg) for micro-catheters with a radius of 0.4,
0.5, and 0.6 mm
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Time to reach target hypothermia temperature
In Appendix 3 an equation is derived that relates the
time necessary to reach a speciﬁc hypothermia temper-
ature to coolant ﬂow rate and infarcted brain mass.
Figure 6 shows the time needed to reach the localized
target hypothermia temperature (displayed horizontally)
for an infarcted massMIB of 300 g and ﬂow rates of 7.5,
15.0, 30.0, and 45.0 ml min)1. As also follows from this
ﬁgure, and which is intuitively expected, the state of
hypothermia is reached as quickly as possible by using as
large as possible ﬂow rates combined with as low as
possible coolant temperatures.
The eﬀect of localized hypothermia on the systemic
temperature
The amount of energy Qcool that is extracted from the
body in the case of systemic hypothermia can be com-
puted from the following equation:
Qcool ¼ mbody Cbody
 
DT ð2Þ
with mbody the mass (kg), ÆCbodyæ the average heat
capacity (J kg)1 K)1), and DT the decrease in tempera-
ture of the body. In the case of mild hypothermia
(DT=4.0C), the average heat capacity of the body is
3.47 kJ kg)1 K)1 and, assuming a body weight of
70.0 kg, Qcool=971.6 kJ. According to Dixon et al. [9],
the state of mild whole-body hypothermia is reached
after approximately 1 h. In the case of locally induced
hypothermia, a worst-case estimate of the eﬀect of the
cold saline infusion on the body temperature can be
made by assuming that all extracted energy contributes
to a global decrease in body temperature.
The decrease in whole-body temperature caused by a
2.0C saline solution, applied at a volume rate /saline of
1,200 ml/h during Dt=1.0 h, can be approximated in the
following way:
DTbody  qsaline/salineDt CsalineDTsaline
mbody Cbody
  ð3Þ
Taking q saline=1.024·103kg m)3, Csaline=3.93 kJ kg)1
K)1, DTsaline=35C, mbody=70.0 kg, and ÆCbody-
æ=3.47 kJ kg)1 K)1 one ﬁnds a DTbody 0.70C. Note
that this is the maximum theoretical possible systemic
decrease in body temperature; in reality the cooling will
only have a local eﬀect, due to the nearly perfect local
heat exchange in the vasculature.
Results
In order to investigate experimentally the usability of
micro-catheters to transport heat, we carried out several
experiments that resembled the in vivo conditions as clo-
sely as possible. In the ﬁrst experiment, a FasTracker-18
micro-catheter (Boston Scientiﬁc) was placed in a water-
containing basin of 37C. Cold water, having an inlet
temperature of approximately 2C (see Table 1 for exact
values), was injected in the micro-catheter. Inlet and
outlet temperatures were measured.
Fig. 6 The time needed to reach a speciﬁc hypothermia tempera-
ture, assuming an initial infarcted tissue temperature of 37C and
an infarcted tissue mass of 300 g. The steepest curve corresponds to
a micro-catheter coolant ﬂow rate (Tmc,out=15C) of 7.5 ml min)1.
Also displayed are the curves for coolant ﬂow rates of 15, 30
and 45 ml min)1
Fig. 5 Cooling curves for four diﬀerent ﬂow rates: /mc,out=7.5,
15.0, 30.0, and 45 ml min)1. The larger the ﬂow rate / mc,out, the
faster the brain cools. Coolant temperature was 15.0C. This simple
temperature model predicts that for long periods of time, the brain
temperature approaches the coolant temperature
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In the second experiment, a seven French Guider
Softip (Boston Scientiﬁc) guiding catheter was placed in
an approximately 37C basin. The micro-catheter was
placed within the guiding catheter that was ﬁlled with
37C water. Again, cold water, having an inlet temper-
ature of approximately 2C (see Table 1 for exact val-
ues), was injected in the micro-catheter. Inlet and outlet
temperatures were also measured.
The third experiment was the same as the second
experiment, but instead of a water-ﬁlled guiding cathe-
ter, an air-ﬁlled guiding catheter was used. Since air is a
good thermal insulator, having a thermal conductivity
coeﬃcient in the same order of magnitude as thermal
isolating plastic foam (e.g. expanded polystyrene, EPS),
this experiment simulates the eﬀect of a thick-walled,
thermally insulated, guiding catheter.
Every individual experiment was repeated twice. With
the aid of Eq. 4, the eﬀective overall heat transfer
coeﬃcient was calculated and is also listed in Table 1.
From the large, eﬀective, overall heat transfer coeﬃcient
k it may be concluded that a plain micro-catheter has
very poor thermal insulation properties. The thermal
insulation could be improved (i.e. lower k value, cf.
Table 1) if the guiding catheter were further insulated
e.g. with plastic foam: the overall heat transfer coeﬃ-
cient could be lowered by a factor of approximately 2.5–
3, as demonstrated by the third experiment. Although
being poor thermal insulators, the outlet temperatures of
Table 1 in the second experiment, which resembles very
close the in vivo situation in everyday clinical practice in
interventional neuroradiology, demonstrate that a mi-
cro-catheter, placed within a blood/saline-containing
guiding catheter, can serve as a coolant transporter to
induce local hypothermia of infarcted areas. With spe-
cial thermally insulated catheters, simulated by the third
experiment, it would be possible to reach even lower
brain temperatures in shorter time. Another possibility
to decrease the outlet temperature of the micro-catheter
is the possibility of ﬂushing the guiding catheter slowly
with cold saline solution.
Discussion
Whole-body hypothermia is reported to have numerous,
unwanted, side eﬀects [10]; these include coagulopathies
[21, 22] that can cause severe bleeding, hypovolaemia [23,
24], arrhythmia, and infections. Although not often ob-
served in mild hypothermia, this excludes the therapeutic
application of hypothermia in patients with a history of
atrial ﬁbrillation and congestive heart failure [4, 5, 25,].
Hypotension, as well as hypertension, may occur,
especially during inductionof hypothermia via the skin, as
a result of the release of catecholamine [26]. Also, pul-
monary complications are observed, mainly related to
surface cooling [25, 27]. In addition, electrolyte abnor-
malities (including hypokalaemia, hyperglycaemia and
metabolic acidosis) have been described [27], and intra-
cranial pressure may increase if rewarming is done too
quickly.
Induced hypothermia, with the aim of reducing the
body’s need for oxygen, can only be successful if the
shivering reaction of the body can be suppressed. This
shivering is a result of the release of catecholamine [26],
which will increase, instead of decrease, the patient’s
demand for oxygen and glucose. The shivering reaction
is reported to occur in classically induced hypothermia
as well as in endovascular-induced hypothermia [9].
Shivering can be suppressed by the application of neu-
romuscular blocking agents such as pancuronium or
vecuronium and sedatives such as diazepam and lo-
razepam to reduce the patient’s anxiety.
The possibility of passing the site of occlusion even
before the blood clot has been dissolved allows the
early reperfusion of the infarcted region with nutri-
tional solutions (e.g. oxygen, arterial blood from the
femoral sheath), the application of drugs that prevent
reperfusion damage (e.g. free-radical scavengers [28]),
combination therapies [29], and also localized hypo-
thermia.
It is hypothesized in this paper that locally induced
hypothermia of only those parts of the body that need a












Heat transfer coeﬃcient k
(W m)2 K)1)
Aa 0.31 1.2 29.9 37.4 550.8
Aa 0.20 1.3 29.6 37.5 346.2
Bb 0.29 2.5 23.3 37.4 294.5
Bb 0.29 2.5 23.5 37.1 303.4
Cc 0.22 2.0 15.6 36.5 126.7
Cc 0.25 2.7 17.3 37.3 155.8
a Micro-catheter placed directly in a warm water basin
bMicro-catheter placed in a seven French Guider Softip (Boston Scientiﬁc) guiding catheter; the guiding catheter is ﬁlled with non-moving
water having the same initial temperature as the basin
c The same experiment as B, but the micro-catheter is now ﬁlled with air in order to simulate a thermal insulator. From these values, an
eﬀective heat transfer coeﬃcient is calculated which is deﬁned from Eq. 1
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slowed metabolism would achieve the same therapeutic
results as systemic hypothermia, at the same time cir-
cumventing the bulk of negative side eﬀects associated
with the latter. Localized hypothermia, as described in
this paper, is not a therapy that is applied on its own but
always in combination with LIT or other intra-arterial
catheter-based techniques. The literature about locally
induced hypothermia is limited, and most of the appli-
cations described in the literature are limited to animal
studies (e.g. [12] and references therein). Recently, Ding
et al. [13] published data of an animal study where
localized endovascular hypothermia using cold saline
solution was applied to transient middle cerebral arterial
occlusion, very similar to the approach described in this
paper. Ding et al. [13] showed signiﬁcant reductions of
infarct volume, up to 90%, and signiﬁcantly improved
motor behaviour compared with the control group.
Their study supports our hypothesis that local, induced,
hypothermia of the ischaemic brain, may substantially
improve the clinical outcome.
From a physical point of view, the previous theoret-
ical and experimental part showed that localized hypo-
thermia of brain tissue jeopardized by ischaemia is, in
principle, possible, with the aid of a combined guiding/
micro-catheter set-up that is used routinely in interven-
tional neuroradiology in the treatment of acute stroke
by local intra-arterial thrombolysis. The instruments
and experience necessary to perform the proposed local
hypothermia in stroke are available in each Department
of Neuroradiology. Therefore, it is expected that the
additional cost to perform the intervention will be
relatively low, when compared with whole-body endo-
vascular techniques. An advantage of locally induced
hypothermia over whole-body hypothermia may be that
no medication is needed to prevent the natural shivering
reaction of the body to hypothermia. It is, however,
uncertain whether shivering-prevention medication will
be necessary in those cases where the hypothalamus is
part of the locally cooled brain region, since the hypo-
thalamus will receive normal body temperature infor-
mation from the body, whereas the local sensors in the
hypothalamus will record too low a local brain tem-
perature. It is diﬃcult to predict what the response of the
hypothalamus will be to this situation. Whole-body
hypothermia is frequently being carried out in combi-
nation with artiﬁcial ventilation of the patient. In the
case of localized hypothermia, artiﬁcial ventilation
would not be necessary in those cases where the respi-
ratory centre of the brain in not aﬀected by the infarc-
tion.
Another possibility, not discussed in this paper, is the
induction of hypothermia just in front of the occlusion
site, resulting in induction of hypothermia primarily of
the penumbra and secondarily of the core of the
infarction by heat conduction and heat transportation
through the cortical ascending veins.
Systemic versus locally induced hypothermia
Compared with systemic hypothermia, the probability
of coagulopathies is less severe in localized hypothermia
since the global blood temperature is only minimally
lowered. Also, the bulk of hypothermia-related dys-
rhythmias, including atrial ﬁbrillation, are prevented in
the case of locally induced hypothermia. This makes
localized hypothermia especially attractive for patients
that are also suﬀering from cardiac diseases.
As was shown above, another advantage of localized
hypothermia over whole-body hypothermia is the fact
that cooling is 30-times faster than in classic whole-body
induced hypothermia via the skin using cooling blan-
kets, etc. Compared with the newest high-tech methods,
which recently became available and that induce whole-
body hypothermia by cooling the blood in the inferior
vena cava, the proposed locally induced hypothermia
method is approximately ten-times faster for a tissue
mass of 300 g. The reason for this is that the tissue
jeopardized by ischaemia is not cooled directly in the
case of systemic hypothermia, since the blood vessel that
feeds the infarcted region is occluded. In this type of
induced hypothermia, the jeopardized tissue is cooled
indirectly by thermal conduction of heat ﬂow from the
ischaemic tissue to the cooled healthy tissue. Thermal
conduction is a relatively slow physical process. In the
case of localized hypothermia, however, the infused
coolant directly cools the ischaemic tissue. Localized
hypothermia, therefore, allows a very rapid slow down
of the metabolic processes, which may widen the ther-
apeutic time window to treat the stroke-aﬀected brain
tissue.
Another issue to be mentioned in the case of whole-
body hypothermia is the fact that, up till now, the
temperature in the ischaemic tissue itself was never
determined in all cited references. In all systemic hypo-
thermia methods it is assumed implicitly that the tem-
perature of the ischaemic jeopardized brain tissue will
follow as rapidly as the well-perfused brain tissue. This is
a doubtful assumption, since the cooling in the ischae-
mic part will be cooled by the slower heat conduction
mechanism and not directly by the ﬂow of cooled blood
through micro-capillaries.
Locally induced hypothermia and vasoconstriction
A natural response of the blood vessel wall to tissue
temperatures below 36.5C is contraction (vasocon-
striction). Further studies have to show whether vaso-
constriction-preventing drugs have to be given
immediately before and during the hypothermia therapy
systematically or whether these drugs can eﬀectively be
supplied locally in low dose by the same micro-catheter
that carries the coolant ﬂuid.
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Micro-catheters and the prevention of secondary
brain injury and reperfusion damage
Animal studies have shown that a combination therapy of
magnesium, tirilazad and mild hypothermia is more
eﬀective [29]) than single therapies in the treatment of
focal cerebral ischaemia. Also, the supplementation of
antioxidants (e.g. vitamin E, vitamin C, andmannitol) to
reduce the eﬀects of reperfusion damage done to the
vascular endothelium has been shown to have promising
eﬀects (e.g. [28]). Glutathione also seems to be an
important antioxidant that might be of great importance
in the prevention of reperfusion injury [30]. In principle,
the proposed endovascular localized cooling method can
be combined with other drug therapies. Since the micro-
catheter directly perfuses the ischaemic tissue, antioxi-
dants and other drugs can eﬀectively be administered in a
low dose, directly to the tissue that requires the medica-
tion.
Factors limiting the maximum cooling rate
There are several limiting factors to the maximum
obtainable cooling rate of the tissue jeopardized by
ischaemia. The ﬁrst is the natural ﬂow rate of the oc-
cluded blood vessel. If the total infarcted volume Vinfarct
is known from either CT or MR images, the upper ﬂow
rate could be computed from the average cerebral ﬂow
rate /cerebral whose value is approximately 46 ml per
100 g brain tissue per minute. The maximum ﬂow rate of





in which q brain is the density of brain tissue in
kilogrammes per cubic metre. Since the coolant is
administered to the body, the maximum amount of
coolant per time unit that can be given to the patient will
depend on the body mass and other infusions given to
the patient at the same time. Another limiting factor is
the maximum outﬂow velocity of the coolant ﬂuid. This
factor is described in Appendix 2. The next step is the
development of a device that is able to pump coolant
ﬂuid through micro-catheters with an adjustable ﬂow
rate and an adjustable outlet temperature.
Combination with other therapies
In order to be able to combine the hypothermia with
osmotherapy and antioxidant therapy to prevent
reperfusion damage, this new device should be able to
supply more than one type of ﬂuid through the same
micro-catheter. With the aid of this device, controlled
and reproducible reperfusion of ischaemic tissue may be
possible, allowing for the development of optimal
reperfusion strategies of infarcted tissue. Besides the
hypothermia, the prototype device may keep the local
hypoperfusion of the ischaemic brain area upright as
long as the thrombotic or thromboembolic occlusion is
present. One possible solution might be to use two
micro-catheters simultaneously, one carrying the
thrombolytic agent close or into the occlusion, the other
passing the thrombus and carrying the coolant and other
medication.
Conclusion
This paper introduces the concept of local endovascular
induced hypothermia using micro-catheters. In vitro
measurements show that the thermal properties of a
micro-catheter placed within a guiding catheter are such
that they allow for rapid cooling of infarcted tissue. For
a cerebral infarction having a mass of 300 g the pro-
posed method cools the tissue more than 30-times faster
than conventional cooling methods that operate via the
skin using cooling blankets, ventilators, and rubbing the
skin with a mix of water and alcohol. The proposed
method would have an approximately ten-times faster
cooling rate than whole-body endovascular cooling de-
vices that cool the whole body via a cooling catheter
endovascularly placed in the inferior vena cava. The
proposed cooling via micro-catheters has the additional
advantage that secondary brain injury preventing drugs
can be administered even before the blood clot has been
dissolved. The micro-catheter also allows for eﬀective
and localized supplementation of drugs that prevent
vasoconstriction, normally occurring as soon as the tis-
sue temperature sinks below 36.5C, allowing for
acceptable perfusion rates despite hypothermia.
Appendix 1
Radiation
The body radiates electromagnetic waves. This radiated
power by the human body, denoted by Pradiation, can be
calculated by:
Pradiation ¼ erS T 4body  T 4ambient
 
ð5Þ
where e is the emissivity of the human skin having a
value of 0.97, r is Boltzmann’s constant
(5.67·10)8 W m)2 K)4), S is the surface of the human
body (assumed to be roughly 2.0 m2 for an adult), Tbody
is the skin temperature, and Tambient is the ambient
temperature. For a skin temperature of 34.0C and an
ambient temperature of 23C, Pradiation is 132.9 W.
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Conduction
The heat transfer rate of the human body due to con-
duction can be calculated in the following way:
Pconduction ¼




in which kair=24·10)3 W m)1 K)1. The distance
parameter d accounts for the distance from the skin
surface where the air temperature drops from Tbody to
Tambient. Assuming d=0.045 m and the same ambi-
ent and skin temperature as in the radiation example,
Pconduction=11.7 W.
Convection
Convection involves the transport of energy by means of
the motion of the heat transfer medium. In the case of
the human body this is the surrounding air. The heat
losses due to convection are more diﬃcult to calculate.
Convection can be approximated using (Eq. 6) by
introducing an eﬀective heated air layer deﬀ. The stron-
ger the air motion, the smaller the heated air layer, and
the larger the energy loss due to convection. Under
surgical conditions, this term is normally negligible.
Perspiration
As soon as the skin temperature reaches 37C, the skin
will begin to sweat. Perspiration will increase rapidly
with increasing skin temperature. A healthy person has a
perspiration volume rate _M of approximately 600 g/day,
but the perspiration volume rate can be up to 1.5 l/h
under extreme conditions [31]. The body is cooled by the
vaporization of water. The vaporization heat Cvap of
water at body temperature is 2.436·103 kJ kg)1. The
perspiration heat transfer rate Pperspiration, expressed in
watts, of a healthy person can thus be calculated as:
Pperspiration ¼ Cvap _M ¼ 16:9W ð7Þ
If the skin temperature drops below 37C, sweating will
stop. A direct consequence of the physical facts pre-
sented above is that, under surgical conditions, the heat
loss due to radiation alone (132.9 W) is larger than the
basal metabolic rate (80–100 W), which means that the
patients have to be warmed actively in order to prevent
unwanted systemic hypothermia.
Appendix 2
Required micro-catheter input pressure
Since the inner radii of micro-catheters are very small, the
input pressures needed to pump coolant ﬂuid through
them are very high. The relationship between the liquid
volume per time unit /V (ﬂow rate) that passes through a
circular tube and the required pressure diﬀerence DP over





in which g is the viscosity of the ﬂuid transported
through the micro-catheter, L is the length of the micro-
catheter, and R is the inner radius of the micro-catheter.
Coolant ﬂuid outﬂow velocity
The output speed, vout, with which the coolant leaves the
micro-catheter, measured in metres per second, depends
on the radius R of the micro-catheter as well as on the
coolant ﬂow rate /V and is given by:
vout ¼ /VpR2 ð9Þ
In order to prevent damage to the blood vessel wall
distal to the occlusion site, the maximum outﬂow
velocity should not exceed a certain maximum value.
Realistic outﬂow velocity values for micro-catheters are
in the order of 1–5 m s)1. The maximum tolerable out-
ﬂow velocity will depend on the ratio between the micro-
catheter’s inner radius and the arterial inner radius. The
smaller this ratio, the higher the maximum tolerable
micro-catheter output velocity, as the coolant ﬂuid jet at
the micro-catheter tip will be slowed down very rapidly
by the eddies that are produced in the non-moving blood
behind the occlusion. To the best of the authors’
knowledge, there exists no safety guideline for the
maximum tolerable micro-catheter output velocity.
When the technique is used clinically, before the thera-
peutic injection of cool saline solution is started, the
position of the tip of the catheter relative to the vessel
wall, as well as the size of each, has to be visualized by
subtle contrast injection as shown in Figs. 2b and 3c.
Appendix 3
The bio-heat equation
For the time-dependent and spatially dependent tem-
perature T in any point of living tissue to be calculated,




¼ r kIBrTð Þ  cBloodWBlood T  TBloodð Þ þ P
ð10Þ
in which q IB is the density of the infarcted brain tissue
(kg m)3), cIB the speciﬁc heat (J kg
)1 K)1), kIB the
thermal conductivity (W K)1 m)1), cBlood the speciﬁc
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heat (J kg)1 K)1) of blood, and WBlood the volumetric
perfusion rate (kg m)3 s)1). The ﬁrst term on the right-
hand side accounts for thermal conductivity, the second
term for heat exchange of the tissue with the arterial
blood and P is the brain tissue’s metabolic heat pro-
duction. Finding solutions to the partial diﬀerential
equation is far from trivial. Here we present an approx-
imate solution by making the following assumptions.
Since the blood vessel is totally occluded the volumetric
perfusion rate of the blood is zero. The ischaemic brain
tissue that was perfused by the artery before it became
occluded is assumed to have total mass MIB. This brain
tissue is during hypothermia treatment solely artiﬁcially
perfused by the micro-catheter having an output ﬂow
rate /mc,out (ml min
)1). Since the tissue is in an ischaemic
state we assume the metabolic rate P to be negligible. We
also assume conductive heat transport to be negligible
and further assume that the heat is uniformly in space
transferred via the arterioles and capillaries. Under these




¼ /mc;outc TIB  TArtery
  ð11Þ






  ¼ j TIB  Tmc;out
  ð12Þ
with c cBlood. With TIB (0)=TIB, 0 and Tmc,out not time
dependent, the following solution is found:
TIBðtÞ¼ TIB;0þ expðj tÞ1ð Þ TIB;0Tmc;out
  ð13Þ
Time to reach target hypothermia temperature
Of more practical use than Eq. 13 is an expression that
relates to the time necessary to reach a speciﬁc hypo-
thermia temperature Thypothermia, while given the mass of
the tissue jeopardized by ischaemia, the coolant tem-
perature, and the coolant ﬂow rate. It can be proven that
the time t needed to reach a target temperature of
Thypothermia (with the additional condition that
Tmc,out < Thypothermia < TIB) is given by:
t Thypothermia
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